Clal Biotechnology reported ILS43.13M in Market Capitalization this July of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Arca Biopharma USD 1.47B 537M Dec/2025
aTyr Pharma USD 42M 37M Jul/2026
Bio Path USD 1000K 0 Sep/2025
Brainstorm Cell Therapeutics USD 8M 3M Sep/2025
Cara Therapeutics USD 366M 338M Sep/2025
Clal Biotechnology ILS 43.45M 8.92M Mar/2026
Compugen USD 573.66M 46.63M Jul/2026
Immunic USD 64M 23M Dec/2025
RedHill Biopharma USD 1000K 4M Jul/2026